TCL Archive Treatment Progress Since 1972 Provides Powerful Support For Continuing National Cancer Program March 23, 1979
TCL Archive Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study June 21, 2002
TCL Archive NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions. December 12, 2003
TCL Archive Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock December 17, 2013
